GH Competitors & Alternatives
Compare Guardant Health Inc with similar stocks in the same industry
Diagnostics & Research
GH
Main Stock$160.05
Tradestie Score
63
Market Cap
$7.81B
Revenue Growth
0.5%
Analyst Upside
-4.7%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MTD
Mettler-Toledo International
|
$1296.17
|
$26.57B | 29.3 | 61 | Compare |
|
LH
Labcorp Holdings Inc.
|
$276.81
|
$23.19B | 24.6 | 65 | Compare |
|
NTRA
Natera, Inc. Common Stock
|
$269.95
|
$22.18B | - | 59 | Compare |
|
DGX
Quest Diagnostics Inc.
|
$207.44
|
$20.36B | 23.0 | 61 | Compare |
|
WAT
Waters Corp
|
$376.43
|
$19.04B | 46.7 | 56 | Compare |
|
ILMN
Illumina Inc
|
$190.20
|
$15.72B | 34.1 | 60 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$538.23
|
$15.28B | 33.7 | 61 | Compare |
|
ICLR
Icon Plc
|
$167.72
|
$14.96B | 74.3 | 51 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 65 | Compare |
|
RVTY
Revvity, Inc.
|
$112.29
|
$10.65B | 52.5 | 61 | Compare |
More GH Analysis
Data updated: Jul 13, 2026 | Industry: Diagnostics & Research (SIC 8071)
37 stocks in this industry